Medical Properties Trust SVP Sells ,304 Stock By Investing.com
Medical Properties Trust SVP Sells ,304 Stock By Investing.com



James Kevin Hanna, senior vice president, controller and chief accounting officer of Medical Properties Trust Inc . (NYSE:), recently sold 11,641 shares of the company’s common stock. The transaction, which took place on December 26, was executed at a price of $3.72 per share, totaling $43,304. Following this sale, Hanna retains ownership of 366,913 shares of the company. According to a footnote in the filing, the sale was part of Hanna’s year-end tax planning, with the intent to potentially repurchase the shares, depending on market conditions and compliance with securities laws and policies. the relevant company. InvestingPro’s analysis indicates the stock is trading at a low price-to-book multiple of 0.42, with additional information available in the comprehensive Pro Research Report covering MPW among over 1,400 US stocks.

In other recent news, Medical Properties Trust has reported several important developments. The company reported a GAAP net loss of $1.34 per share for the third quarter of 2024, while its normalized funds from operations came in at $0.16 per share. In a strategic move, Medical Properties Trust entered into a definitive agreement with Astrana Health for a deal valued at approximately $745 million, including the sale of most of Prospect’s managed care platform.

The company expects to earn about $200 million in cash proceeds after settling debt and other liabilities, with the majority of the cash proceeds anticipated in the first half of 2025. Truist Securities revised its price target on shares of Medical Properties Trust at $4.00, maintaining a Maintain the stock’s rating, highlighting important maturities and a high cost of capital.

Medical Properties Trust also settled a defamation lawsuit with Viceroy Research, although details of the settlement remain undisclosed. These recent developments come amid disappointing capital allocation and risk management practices at the company, as well as a substantial amount of overdue debt. Investors are expected to closely monitor the progress of the recently transferred Steward Hospitals and how effectively management is able to recapitalize the company.

This article was generated with the support of AI and reviewed by an editor. For more information consult our T&C.

By Admin

Leave a Reply

Your email address will not be published. Required fields are marked *